retatrutide nonalcoholic steatohepatitis trial Results from a new efficacy and safety analysis of the REGENERATE of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic Phase 2 trial results demonstrate

Your provider will help you evaluate the benefits and risks of each

Fund Details Issuer Roundhill Investments Fund Name Roundhill GLP-1 & Weight Loss ETF Tax Classification Regulated Investment Company Stock Exchange NASDAQ Current Symbol NASDAQ:OZEM Inception Date 5/20/2024 Fund Manager Will Hershey, Tim Maloney, Dave Mazza, Drew Walsh Previous Symbol NASDAQ:OZEM Web N/A Phone N/A Fund Focus Asset Class Equity Benchmark N/A Category Strategy Focus Theme Development Level Blended Development Region Global Number of Holdings 53 Fund Statistics Assets Under Management $0.00 Average Daily Volume $0.00 Discount/Premium 0.00% Administrator, Advisor and Custodian Administrator U.S

Any future use would depend on licensing and regulatory approval in the UK

Use a clinician-approved fiber, fluid, activity, or medicine plan rather than repeated detoxes. Review Meal Fat and Size Large high-fat meals can delay stomach emptying and worsen fullness or reflux, especially during GLP-1 treatment

Do not freeze reconstituted retatrutide

Light exposure can reduce stability